SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-053973
Filing Date
2006-08-11
Accepted
2006-08-11 13:55:21
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-15701_110q.htm 10-Q 698312
2 EX-31 a06-15701_1ex31d1.htm EX-31.1 8474
3 EX-31 a06-15701_1ex31d2.htm EX-31.2 9205
4 EX-32 a06-15701_1ex32d1.htm EX-32.1 4414
5 EX-32 a06-15701_1ex32d2.htm EX-32.2 4268
6 GRAPHIC g157011bai001.gif GRAPHIC 2968
7 GRAPHIC g157011be01i001.jpg GRAPHIC 877
  Complete submission text file 0001104659-06-053973.txt   731746
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 061024186
SIC: 2834 Pharmaceutical Preparations